Evidence map›Paper›PMID 31528350›Full record

ArticleMaterials horizons2017

LiGa

Hongmin Chen, Xilin Sun, Geoffrey D Wang, Koichi Nagata, Zhonglin Hao, Andrew Wang, Zibo Li, Jin Xie, Baozhong Shen

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials horizons, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 171 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Pure Organic AIE Nanoscintillator for X-ray Mediated Type I and Type II Photodynamic Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  16. Review
  17. Article
  18. Seeing cancer via sonoafterglow.Nature biomedical engineering · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Hongmin Chen *Molecular Imaging Research Center (MIRC), TOF-PET/CT/MR center, The Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang 150028, China.
Xilin Sun *Molecular Imaging Research Center (MIRC), TOF-PET/CT/MR center, The Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang 150028, China.
Geoffrey D WangDepartment of Chemistry, University of Georgia, Athens, Georgia 30602, USA.
Koichi NagataCollege of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Zhonglin HaoSection of Hematology and Oncology, Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, Georgia 30912, USA.
Andrew WangDepartment of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Zibo LiΔDepartment of Radiology and Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jin XieDepartment of Chemistry, University of Georgia, Athens, Georgia 30602, USA.
Baozhong ShenMolecular Imaging Research Center (MIRC), TOF-PET/CT/MR center, The Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang 150028, China.
Harbin University · CNUniversity of Georgia · USUniversity of North Carolina at Chapel Hill · USAugusta University · US

Funding

Combined Nanoparticle and Neural Stem Cell Therapies in a Pig Model of StrokeR01NS093314 · NINDS · UNIVERSITY OF GEORGIA · PI WEST, FRANKLIN D · 2015 to 2019
$2.4M
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiationR01EB022596 · NIBIB · UNIVERSITY OF GEORGIA · PI XIE, JIN · 2017 to 2020
$1.9M
NIBIB NIH HHS R01 EB022596NINDS NIH HHS R01 NS093314
6 · The paper itself

Abstract

Using X-ray as the irradiation source, a photodynamic therapy process can be initiated from under deep tissues. This technology, referred to as X-ray induced PDT, or X-PDT, holds great potential to treat tumors at internal organs. To this end, one question is how to navigate the treatment to tumors with accuracy with external irradiation. Herein we address the issue with a novel, LiGa

Indexed as

Nanomedicinenanotheranosticsnon-small cell lung cancerphotodynamic therapyX-ray excited optical luminescence

Identifiers

PMID31528350
PMCPMC6746429
OpenAlexW2744106462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.